News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Marshall Ken W.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2023 |
4
| Marshall Ken W. (SVP, Chief Commercial Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 75,000 rights
@ $0 |
|
| 05/05/2023 |
4
| Marshall Ken W. (SVP, Chief Commercial Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 75,000 rights
@ $0 |
|
| 03/09/2023 |
4
| Marshall Ken W. (SVP, Chief Commercial Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 150,000 shares
@ $0 |
|
| 11/08/2022 |
4
| Marshall Ken W. (SVP, Chief Commercial Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.875, valued at
$35k
|
|
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2018 |
4
| Marshall Ken W. (Commercial Leader) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Bought 1,445 shares
@ $10.15, valued at
$14.7k
|
|
| 07/24/2018 |
3
| Marshall Ken W. (Commercial Leader) has filed a Form 3 on Aquestive Therapeutics, Inc. |
|
|